2024-12-16 - Analysis Report
## Albemarle Corp (ALB) Stock Review

This report analyzes Albemarle Corp (ALB), a leading global producer of lithium and bromine-based specialty chemicals, based on the provided data.

**1. Performance Comparison with S&P 500 (VOO):**

Albemarle's cumulative return (10.01%) significantly underperformed the S&P 500's cumulative return (120.91%) over the analyzed period.  The difference is a substantial -110.9 percentage points.  The relative divergence of -110.9 places it at the 2.9th percentile of its historical range, indicating significantly weaker performance compared to the S&P 500.

**2. Recent Price Movement:**

* **Closing Price:** $99.38
* **5-Day Moving Average:** $104.03
* **20-Day Moving Average:** $106.13
* **60-Day Moving Average:** $100.29

The stock price is currently trading below all three moving averages, suggesting a bearish short-term trend.

**3. Technical Indicators and Expected Return:**

* **RSI (38.43):**  Indicates the stock is approaching oversold territory, potentially suggesting a bounce.
* **PPO (-1.06):**  Shows a negative momentum, aligning with the bearish price trend.
* **20-Day Relative Divergence (-1.4):** Shows a recent downward trend in relative performance.
* **Expected Return (0.0%):**  The provided data indicates no expected excess return over the S&P 500 for long-term (2+ years) investment, considering the current valuation.  This is consistent with underperformance and signals the need for further investigation.  The current price ($99.38) being below moving averages does not suggest a significant immediate price movement (i.e., no 급반등 or 급하락 indicated by the data).


**4. Recent Earnings Analysis:**

The recent earnings reports show a significant decline in EPS and mixed revenue trends.

* **EPS Trends:**  A sharp drop in EPS from Q3 2023 ($2.58) to subsequent quarters, reaching -$9.45 in Q4 2024.  This indicates a substantial deterioration in profitability.
* **Revenue Trends:** Revenue fluctuated around $1.35B-$1.43B in the last three quarters of 2024, significantly lower than the $2.31B in Q3 2023. This suggests a substantial revenue decline.
* **Comparison:**  The significant decline in EPS and revenue compared to Q3 2023 is notable and requires further investigation into underlying causes.  The reported numbers lack context of expectations, preventing an assessment of beats or misses.


**5. Financial Information Analysis:**

Both revenue and profitability have significantly deteriorated from Q3 2023 to Q3 2024.  Profit margins have turned negative and are significantly lower than the previous year.  Similarly, ROE has dropped into negative territory in recent quarters.  Equity has fluctuated, but the overall trend shows a decrease in profitability and a weakening financial position.


**6. News and Recent Issues:**

The provided data lacks information on recent news, market outlook, and analyst opinions within the last two days.  This information is crucial for a complete analysis.


**7. Overall Analysis:**

Albemarle has significantly underperformed the S&P 500 over the analyzed period.  Recent earnings show a dramatic decline in both EPS and revenue, indicating significant challenges for the company. Technical indicators point to a bearish short-term trend.  The lack of news and analyst data prevents a comprehensive assessment of current market sentiment and future outlook.  The 0% expected return relative to the S&P 500 suggests caution is warranted before investing, particularly in the current context of poor financial performance. Further investigation into the causes of the EPS and revenue decline is needed to form a complete investment thesis.

**8. Disclaimer:** This analysis is based solely on the provided data and does not constitute financial advice.  Investing in the stock market involves risks, and past performance is not indicative of future results.  Conduct thorough independent research and consider consulting a financial advisor before making any investment decisions.
